Ingredion Takeover Target Tate & Lyle Posts Fall in Profit
The British ingredients company reported lower profit for what it called a disappointing fiscal year.
INGR - Ingredion Incorporated
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$117.00
DETAILS
HIGH:
$120.00
LOW:
$114.00
MEDIAN:
$117.00
CONSENSUS:
$117.00
UPSIDE:
14.25%
Stock News
Ingredion Incorporated Declares Quarterly Dividend of $0.82 Per Share
WESTCHESTER, Ill., May 20, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions, announced today that its board of directors declared a quarterly dividend of $0.82 per share on the Company's common stock.
Ingredion: Oversold After Argo Issues, Acquisition Could Change The Story
Ingredion Incorporated (INGR) remains a Buy, supported by strong financials and robust cash generation despite recent operational setbacks and macro pressures. Q1 results were weak due to Argo facility issues, leading to reduced 2026 guidance and highlighting operational and cost risks. Potential acquisition of Tate & Lyle could transform INGR, expanding geographic reach significantly and helping to diversify into higher-growth segments.
Tate & Lyle In Talks With Ingredion Over $3.7 billion Takeover Offer
The proposed offer value is a 64% premium to the London-listed food-and-beverage ingredient company's closing share price Wednesday.
Britain's Tate & Lyle in discussions with US rival Ingredion for $3.7 billion takeover bid
Britain's Tate & Lyle on Thursday said it was in discussions with U.S. rival Ingredion over a possible takeover of the food ingredients maker, valuing it at 2.74 billion pounds ($3.70 billion), after receiving multiple approaches.
Big Idea Ventures and Mars Petcare Launch 2026 Global Pet Food Innovation Program in Collaboration with AAK, Bühler, Givaudan, and Ingredion
An Innovation Powerhouse: The initiative unites world-class experts in FoodTech, pet care, and ingredients to accelerate the transition toward a more sustainable pet food supply chain. Seeking New and Scaling Ventures: The program is in pursuit of bold companies with groundbreaking solutions in alternative proteins, fats, oils and novel ingredients.
Ingredion Q1 Earnings Call Highlights
Ingredion NYSE: INGR reported a weaker-than-expected first quarter of 2026, as operational problems at its Argo facility weighed heavily on results in its Food & Industrial Ingredients U.S. Canada segment, while its Texture & Healthful Solutions business continued to post volume growth.
3 AgTech & Food Innovation Stocks to Watch as Food Systems Evolve
DE, ADM & TSN tap AgTech and food innovation trends as demand grows for smarter farming, sustainable ingredients and protein solutions.
Ingredion Incorporated (INGR) Q1 2026 Earnings Call Transcript
Ingredion Incorporated (INGR) Q1 2026 Earnings Call Transcript
Ingredion (INGR) Lags Q1 Earnings Estimates
Ingredion (INGR) came out with quarterly earnings of $2.34 per share, missing the Zacks Consensus Estimate of $2.44 per share. This compares to earnings of $2.97 per share a year ago.
Ingredion Incorporated Reports First Quarter 2026 Results
First quarter 2026 reported and adjusted* operating income decreased 26% and 22% compared to the first quarter 2025 First quarter 2026 reported and adjusted EPS were $2.22 and $2.34, compared with $3.00 and $2.97 in the first quarter 2025 Adjusting full-year guidance for reported EPS to be in the range of $9.60 to $10.30 and adjusted EPS to be in the range of $10.45 to $11.15 WESTCHESTER, Ill., May 05, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its first quarter 2026 results.
Earnings Preview: Ingredion (INGR) Q1 Earnings Expected to Decline
Ingredion (INGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Boston Trust Walden Corp Sells 134,874 Shares of Ingredion Incorporated $INGR
Boston Trust Walden Corp cut its stake in Ingredion Incorporated (NYSE: INGR) by 98.5% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,041 shares of the company's stock after selling 134,874 shares during the period. Boston Trust Walden Corp's holdings in
Atlantic Edge Private Wealth Management LLC Sells 7,945 Shares of Ingredion Incorporated $INGR
Atlantic Edge Private Wealth Management LLC trimmed its position in Ingredion Incorporated (NYSE: INGR) by 64.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 4,374 shares of the company's stock after selling 7,945 shares during the period. Atlantic Edge Private Wealth Management LLC's holdings
Ingredion to Release 2026 First Quarter Financial Results On May 5, 2026
WESTCHESTER, Ill., April 14, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, will release its first quarter 2026 financial results for the period ended March 31, 2026, before the market opens Tuesday, May 5, 2026.
Massachusetts Financial Services Co. MA Sells 34,950 Shares of Ingredion Incorporated $INGR
Massachusetts Financial Services Co. MA lessened its holdings in shares of Ingredion Incorporated (NYSE: INGR) by 2.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,334,498 shares of the company's stock after selling 34,950 shares during the quarter. Massachusetts Financial Services Co.
Assenagon Asset Management S.A. Has $3.35 Million Holdings in Ingredion Incorporated $INGR
Assenagon Asset Management S.A. increased its holdings in shares of Ingredion Incorporated (NYSE: INGR) by 25.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 30,335 shares of the company's stock after acquiring an additional 6,060 shares during the quarter. Assenagon
Ingredion Announces Retirement of Gregory B. Kenny, Director, and Names Siobhán Talbot to Board of Directors
WESTCHESTER, Ill., March 23, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions for food, beverage and industrial applications, today announced the retirement of long-serving board member Gregory B. Kenny, effective immediately, and the appointment of Siobhán Talbot to its board of directors, effective April 1.
Head to Head Contrast: Ingredion (NYSE:INGR) and Tate & Lyle (OTCMKTS:TATYY)
Tate and Lyle (OTCMKTS:TATYY - Get Free Report) and Ingredion (NYSE: INGR - Get Free Report) are both consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, profitability and earnings. Dividends Tate and Lyle pays an annual
3 AgTech & Food Innovation Picks Riding on Structural Growth Trends
In the evolving AgTech & Food Innovation space, ADM, BYND and INGR are moving beyond traditional commodity models, using science and technology to pursue higher-value growth.
Price Targets
Ingredion price target lowered to $114 from $122 at UBS
$114.00
(was $106.31)
Joshua Spector
·
UBS
Ingredion price target lowered to $120 from $128 at Barclays
$120.00
(was $107.13)
Benjamin Theurer
·
Barclays
Ingredion price target lowered to $122 from $124 at UBS
$122.00
(was $114.93)
UBS
Ingredion price target raised to $124 from $119 at UBS
$124.00
(was $119.96)
UBS
Ingredion price target raised to $128 from $124 at Barclays
$128.00
(was $120.41)
Barclays
Ingredion downgraded to Equal Weight from Overweight at Barclays
$124.00
(was $107.70)
Industrial Alliance Securities
Ingredion price target lowered to $123 from $143 at BMO Capital
$123.00
(was $107.02)
Andrew Strelzik
·
BMO Capital
Ingredion price target lowered to $136 from $157 at Oppenheimer
$136.00
(was $120.93)
Oppenheimer
Ingredion price target lowered to $130 from $144 at UBS
$130.00
(was $120.42)
UBS
Ingredion price target lowered to $155 from $167 at Oppenheimer
$155.00
(was $130.77)
Kristen Owen
·
Oppenheimer
Ingredion price target lowered to $155 from $167 at Oppenheimer
$155.00
(was $130.77)
UBS
Ingredion (INGR) PT Raised to $147 at Oppenheimer
$147.00
(was $134.12)
Kristen Owen
·
Oppenheimer
Ingredion upgraded to Overweight from Equal Weight at Barclays
$145.00
(was $126.76)
Benjamin Theurer
·
Barclays
Ingredion (INGR) PT Raised to $128 at BMO Capital
$128.00
(was $126.37)
Andrew Strelzik
·
BMO Capital
Ingredion (INGR) PT Raised to $138 at Oppenheimer
$138.00
(was $126.37)
Kristen Owen
·
Oppenheimer
Ingredion (INGR) PT Raised to $120 at BMO Capital
$120.00
(was $118.09)
Andrew Strelzik
·
BMO Capital
Ingredion (INGR) PT Raised to $126 at Oppenheimer
$126.00
(was $118.45)
Kristen Owen
·
Oppenheimer
Goldman Sachs Upgrades Ingredion (INGR) to Buy, 'rising balance sheet optionality'
$135.00
(was $114.91)
Adam Samuelson
·
Goldman Sachs
Ingredion's Growth Strategy To Please Health-Conscious Consumers Can Make It A Winner: Analyst
$120.00
(was $98.46)
Kristen Owen
·
Oppenheimer